ENTITY
SK Bioscience

SK Bioscience (302440 KS)

232
Analysis
Health Care • South Korea
SK Bioscience Co.,Ltd. operates biopharmaceutical businesses. The Company produces vaccines, sky cellflu prefilled syringes, sky cellflu quadrivalent prefilled syringes, varicella drugs, and other related products. SK Bioscience markets its products throughout South Korea.
more
bullish•Soop
•02 Feb 2022 07:42

KRX K-New Deal Index Screening Period Ended: Rebalancing Changes & Passive Impacts Update

The KRX K-New Deal Index's screening period ended last Friday. This post updates the screening results and passive impacts.

Logo
438 Views
Share
•30 Jan 2022 16:58

NPS Exclusively Buying LG Energy Solution At the Expense of Other 2,400+ Stocks in Korea

In this insight, we discuss the details of how the local pension funds strongly supported LG Energy Solution IPO's stock price on January 27th and...

Logo
479 Views
Share
•21 Jan 2022 18:48

LG Energy Solution: Confirmed Allocations, Float, & Lock-Up Periods

The final tally for the locked-up shares of LG Energy Solution IPO is 13.6 million shares, representing 58.3% of total shares allocated for the...

Logo
679 Views
Share
•17 Dec 2021 04:57

LG Energy Solution - What Are the Locals Saying About This IPO?

The local market is generally positive on the LG Energy Solution IPO. Valuations are reasonable and many investors expect the IPO to be priced at...

Logo
665 Views
Share
x